Sulfazamet

Sulfazamet

SCHEMBL193436

Cc1cc(NS(=O)(=O)c2ccc(N)cc2)n(-c2ccccc2)n1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.81
POLB P06746 2/20 0.74
TERT O14746 1/20 0.64
CYP2C9 P11712 5/20 0.63
CYP2C19 P33261 4/20 0.63
LMNA P02545 2/20 0.63
CYP2C18 P33260 2/20 0.63
CYP3A4 P08684 2/20 0.63
TDP1 Q9NUW8 2/20 0.63
TSHR P16473 1/20 0.63
NFKB1 P19838 1/20 0.63
THPO P40225 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
HSD17B10 Q99714 1/20 0.63
NTRK1 P04629 1/20 0.52
GAA P10253 2/20 0.51
MAPK1 P28482 2/20 0.51
HPGD P15428 1/20 0.51
CYP2C8 P10632 1/20 0.51
PDE4A P27815 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfazamet SCHEMBL28263614 0.95 ALDH1A1 (0.74) ALDH1A1POLBTERTCYP2C9CYP2C19
Sulfazamet SCHEMBL28264721 0.87 SCN9A (0.67) ALDH1A1POLBTERTCYP2C9CYP2C19
SCHEMBL15070680 0.80 CYP2C9 (0.60) ALDH1A1POLBCYP2C9CYP2C19LMNA
Sulfaphenazole SCHEMBL122040 0.77 CYP2C9 (1.00) POLBCYP2C9CYP2C19LMNACYP2C18
Sulfaphenazole SCHEMBL14837290 0.76 CYP2C9 (0.75) ALDH1A1POLBCYP2C9CYP2C19LMNA
SCHEMBL14132556 0.76 ALDH1A1 (0.75) ALDH1A1POLBCYP2C9CYP2C19LMNA
SCHEMBL8551416 0.73 ALDH1A1 (0.70) ALDH1A1POLBLMNATSHRNPSR1
SCHEMBL15218510 0.73 ALDH1A1 (0.60) ALDH1A1POLBTERTCYP2C9CYP2C19
SCHEMBL25351301 0.73 ALDH1A1 (0.60) ALDH1A1POLBCYP2C9LMNATDP1
SCHEMBL712299 0.72 SCN9A (0.68) ALDH1A1POLBGAAMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536217-A1 CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS Fleurir Abx LLC (US) 2025-04-16 EP claimed
US-20250099557-A1 ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) 2025-03-27 US claimed
EP-4374848-A1 ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION Shanghai Bao Pharmaceuticals Co., Ltd. (CN) 2024-05-29 EP claimed
CN-117858696-A Antibiotic pharmaceutical composition capable of subcutaneous administration 上海宝济药业股份有限公司 2024-04-09 CN claimed
CN-117471010-A Method for simultaneously detecting various antibiotic residues in hermatypic coral 海南大学 2024-01-30 CN claimed
CN-117384259-A Cell penetrating peptides based on influenza virus M2 proteins 中国医学科学院基础医学研究所 2024-01-12 CN claimed
WO-2024001401-A1 CRYSTAL FORM A OF PYROXASULFONE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 安徽久易农业股份有限公司 2024-01-04 WO claimed
US-20230398101-A1 Co-agents as Therapy Against Anaerobic Pathogens FLEURIR ABX LLC (US) 2023-12-14 US claimed
WO-2023239822-A1 CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS FLEURIR ABX LLC (US) 2023-12-14 WO claimed
CN-117092227-A Method for rapidly screening multiple veterinary drug residues in milk 黑龙江飞鹤乳业有限公司 2023-11-21 CN claimed
WO-2004004658-A2 METHODS AND COMPOSITIONS RELATING TO ISOLEUCINE BOROPROLINE COMPOUNDS POINT THERAPEUTICS, INC. (US) 2004-01-15 WO claimed
US-6573254-B1 Administering to avian species amount of sulfonamide which inhibits production of thyroid hormone and stimulates gonadotropins, exposing avian species to long photoperiod for time sufficient to stimulate production of sperm UNIVERSITY OF MARYLAND 2003-06-03 US claimed
EP-1054588-A4 METHOD FOR THE STIMULATION OF SPERM PRODUCTION AND GONADAL DEVELOPMENT IN ANIMALS UNIV MARYLAND (US) 2002-09-25 EP claimed
EP-1054588-A1 METHOD FOR THE STIMULATION OF SPERM PRODUCTION AND GONADAL DEVELOPMENT IN ANIMALS UNIVERSITY OF MARYLAND (US) 2000-11-29 EP claimed
WO-1999038376-A1 METHOD FOR THE STIMULATION OF SPERM PRODUCTION AND GONADAL DEVELOPMENT IN ANIMALS UNIVERSITY OF MARYLAND (US) 1999-08-05 WO claimed
EP-0572560-A4 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY. SHAPIRO HOWARD K (US) 1995-04-26 EP claimed
EP-0572560-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO, Howard, K. (US) 1993-12-08 EP claimed
WO-1992014456-A1 USE OF PHARMACEUTICAL COMPOUNDS IN THE TREATMENT OF SYMPTOMS OF DISORDERS RELATED TO NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO HOWARD K (US) 1992-09-03 WO claimed
US-4599416-A Process for the preparation of aqueous solutions of potentiated sulfonamides HOFFMANN-LA ROCHE INC. (US) 1986-07-08 US claimed
US-4532245-A Pharmaceutical compositions HOFFMANN-LA ROCHE INC. (US) 1985-07-30 US claimed